OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Chimerix Inc/  US16934W1062  /

NASDAQ
5/23/2024  10:00:00 PM Chg. -0.0208 Volume Bid2:15:06 PM Ask2:15:06 PM High Low
0.9422USD -2.16% 188,276
Turnover: 172,658.6511		 0.9300Bid Size: 5,100 0.9899Ask Size: 1,000 0.9700 0.9301
GlobeNewswire 5/1 Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update
GlobeNewswire 4/24 Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, ...
GlobeNewswire 4/16 Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 3/21 Chimerix Appoints Marc D. Kozin to Board of Directors
GlobeNewswire 2/29 Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
GlobeNewswire 2/22 Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Upd...
GlobeNewswire 2/6 atai Life Sciences Appoints Anne Johnson as Chief Financial Officer
GlobeNewswire 12/29/2023 Chimerix Appoints Lisa Decker to Board of Directors
GlobeNewswire 12/4/2023 Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer
GlobeNewswire 11/24/2023 Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 11/16/2023 Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating an...
GlobeNewswire 11/2/2023 Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update
GlobeNewswire 10/26/2023 Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on Novembe...
GlobeNewswire 9/5/2023 Chimerix to Participate in Upcoming Investor Conferences
GlobeNewswire 8/16/2023 Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC20...
GlobeNewswire 8/16/2023 Teknova Announces New Board Member, Martha J. Demski
GlobeNewswire 3/21/2022 Chimerix to Present at Maxim Group 2022 Virtual Growth Conference
GlobeNewswire 3/1/2022 Chimerix Reports Fourth Quarter and Year End 2021 Financial Results and Provides Operational Update
GlobeNewswire 2/28/2022 Chimerix to Present at Cowen and Company 42nd Annual Health Care Conference
GlobeNewswire 2/24/2022 Chimerix, in Collaboration with the Rapidly Emerging Antiviral Drug Development Initiative (READDI) ...
GlobeNewswire 2/22/2022 Chimerix to Report Fourth Quarter and Year End 2021 Financial Results and Provide an Operational Upd...
GlobeNewswire 1/20/2022 Chimerix to Present at B. Riley Virtual Oncology Conference
GlobeNewswire 1/3/2022 Chimerix to Present at Virtual H.C. Wainwright BioConnect 2022 Conference
GlobeNewswire 12/11/2021 Annual Changes to the Nasdaq Biotechnology Index
GlobeNewswire 11/19/2021 Chimerix Announces Positive ONC201 Data in Recurrent H3 K27M-mutant Diffuse Midline Glioma to Be Pre...